The Patent Finder

Kindex Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Kindex Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Kindex Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,828,331Tetrahydro-isohumulone derivatives, methods of making and using
Lapsed on the fee record
Ended Nov 28, 2025 · USPTO record
Lapsed on the fee recordEnded Nov 28, 2025USPTO record
US 8,410,178CIS 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods
Lapsed on the fee record
Ended Apr 2, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 2, 2025USPTO record
US 8,410,179Cis, 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-derivatives, substantially enantiomerically pure compositions and methods
Lapsed on the fee record
Ended Apr 2, 2025 · USPTO record
Lapsed on the fee recordEnded Apr 2, 2025USPTO record
US 9,340,479Methods of synthesizing alpha acids and substantially enantiomerically pure compositions thereof
Lapsed on the fee record
Ended May 17, 2024 · USPTO record
Lapsed on the fee recordEnded May 17, 2024USPTO record
US 10,343,977Tetrahydro-isohumulone derivatives, methods of making and using
Lapsed on the fee record
Ended Jul 9, 2023 · USPTO record
Lapsed on the fee recordEnded Jul 9, 2023USPTO record
US 8,829,056Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl) cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods
Lapsed on the fee record
Ended Sep 9, 2022 · USPTO record
Lapsed on the fee recordEnded Sep 9, 2022USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited